Would it be very wrong to use this information in helping to decide whom to treat? Although not conventionally significant, the Metoprolol in Acute Myocardial Infarction (MIAMI) trial [ 3 ] leant support to the ISIS-1 trial and was the most important other contributor to the meta-analysis.
1
—
—